BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 18, 2014
View Archived Issues
Sosei subsidiary to commence development of two ophthalmic products
Read More
Universite de Montreal receives grant from Quebec government for drug development
Read More
Regeneron initiates phase I study of intravitreal REGN-2176-3 for wet AMD
Read More
Inhibition of protein kinase-induced gene expression is protective against influenza virus infection
Read More
Bayer initiates new phase III study of rivaroxaban within EINSTEIN program
Read More
GSK researchers present data on novel LSD1 inhibitors
Read More
Biomarker-driven development of resminostat
Read More
Russian group claims new peptide-based compounds for Abeta accumulation
Read More
Galapagos completes recruitment in phase II GLPG-0974 trial
Read More
Last patient treated in phase III CicloMulsion study
Read More
AXIN2 gene as a potential new biomarker for prostate cancer recurrence
Read More
Novartis acquires CoStim Pharmaceuticals
Read More
HIV vaccine obtains FDA orphan drug status for pediatric HIV/AIDS infection
Read More
Canadian researchers design novel MAbs to human GnRH receptor
Read More
Bristol-Myers Squibb divulges novel agents for thromboembolic disorders
Read More
FDA grants orphan drug status to rosuvastatin calcium in pediatric HoFH
Read More
American and Chinese researchers synthesize novel agents for cancer
Read More
Cellectis and Servier enter collaboration to develop allogeneic cell therapies for cancer
Read More
Sunshine Biopharma builds mouse models to test Adva-27a in pancreatic cancer
Read More
Achelios Therapeutics to begin phase Ib study of topical ELS-M11 for migraine
Read More
National Comprehensive Cancer Network recommends Yondelis in trials of uterine leiomyosarcoma
Read More
DBV Technologies and Mount Sinai enter collaboration to develop Viaskin for Crohn's disease
Read More
Phase III trial of Bayer's long-acting, site-specific recombinant factor VIII meets primary endpoint
Read More
Daiichi Sankyo and UMN Pharma form research collaboration to develop norovirus vaccine
Read More